About
For Media
For Sponsors
Home
Search
CONFERENCES
By Topic of Interest
Benefits & Wellness
Business Practices
Information Technology
Policy & Reform
Quality & Care Delivery
By Industry
Benefit, HR & Wellness
Government & Policy
Health Plan & Insurer
Hospital & Health System
By Conference Series
World Health Care Congress
Leadership Summits
Health and Human Capital
Available in Live Webcast
All Events
OPPORTUNITIES
Sponsorship
Exhibiting
Speaking
Marketing
Online Advertising
Inquiry Form
NEWS & PRESS
Media Coverage
Press Releases
Industry News
Media Tips
Health|Watch e-Newsletter
MULTIMEDIA
Videos
Podcasts
Interviews
Facebook
Health Care Blog
COMPENDIUMS
TESTIMONIALS
COMPANY
About World Congress
Careers
Registration Guidelines
Contact
Directions
Privacy Policy
Conference Info
Congress Home Page
Request A Brochure
Accreditation
Pricing & Venue
Executive Team Pricing
Buyers Guide
Posters in Innovation
VIP Membership
Who Should Attend
Testimonials
Healthways Road Race
Executive Spotlight Interview Series
Contact
Agenda & Speakers
Agenda At A Glance
Keynotes/Overview
Co-Located Summits
Emerging Trend Forums
» ETF A
» ETF B
» ETF C
» ETF D
» ETF E
» ETF F
» ETF G
» ETF H
» ETF I
Innovation Series
Market Insights
Grameen Creative Lab
World Health Innovation Summit
2010 Speaker Faculty
2010 Advisory Board
Woman Business Leaders Brunch
Submit an Abstract
Sponsors
Sponsors/Partners
Press & Media
Press Registration and Media Coverage
WHCC Archives
WHCC 2009 Archive
Mailing List
Try Again
Registration Policies
Orders/Cancellations
Opportunities
Sponsorship
Exhibitor
Marketing
Speaking
Page Options
Printer Friendly
Email A Colleague
Bookmark Page
Emerging Trend Forum G: Molecular Diagnostics—360° of Collaboration for Early Identification for Improved Outcomes
Monday, April 12, 2010
11:35am - 12:35pm
Advancing genetic and molecular testing to enable more precise treatment options and improved clinical outcomes
Exploring a new era in diagnostics to identify high risk patients early and to identify appropriate therapies
360° collaboration between labs, providers and payers to more effectively diagnose and to provide more personalized care
Identifying which molecular and genetic tests are covered by insurers and forecasting future trends
Anne Boland Docimo, MD, MBA
Chief Medical Officer,
UPMC Health Plan
;
Medical Directory, Corporate Care Management,
UPMC
View Biography
Tom Tiffany
Chief Executive Officer and President
Pathology Associates Medical Laboratories
Moderator:
Douglas J. Moeller, MD
Medical Director
McKesson
View Biography
Back To Top